Related Experiment Video
Updated: Jul 19, 2026
07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Do polymorphisms in the human 5-HT3 genes contribute to pathological phenotypes?
1Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark. krz@dfuni.dk
Biochemical Society Transactions
|October 21, 2006
Summary
Genetic variations in serotonin 5-HT3 receptors are linked to various diseases. Understanding these genetic links can improve disease diagnosis and treatment strategies for conditions like IBS and psychiatric disorders.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- 5-HT3 receptors are ligand-gated ion channels crucial for neurotransmission in the central and peripheral nervous systems.
- These receptors play a role in conditions such as chemotherapy-induced nausea/emesis, irritable bowel syndrome, and psychiatric disorders.
Purpose of the Study:
- To review genetic association studies linking 5-HT3 receptor subunit genes to disease phenotypes.
- To explore how in vitro characterization of genetic variants can elucidate gene-disease causal relationships.
Main Methods:
- Literature review of genetic association studies.
- In vitro functional characterization of naturally occurring genetic variants.
Main Results:
- Summarizes evidence for the contribution of specific 5-HT3 subunit genes to various disease phenotypes.
- Highlights the importance of genetic variations in understanding receptor function and disease.
Conclusions:
- Genetic variations in 5-HT3 receptors are implicated in a range of diseases.
- In vitro studies of genetic variants are essential for establishing causal links between genes and diseases.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...